Functions of M&uuml;ller cell-derived vascular endothelial growth factor in diabetic retinopathy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

559

HTML

4170

Figures (1-1)

263

Tables (1-2)

203

Sum=5195

Jun 10, 2015 (publication date) through Sep 19, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Diabetes. Jun 10, 2015; 6(5): 726-733
Published online Jun 10, 2015. doi: 10.4239/wjd.v6.i5.726

Table 2 Pathological changes in diabetic or hypoxic Müller cell-specific KO mice

Model	Pathological changes	Alteration
STZ-induced diabetes	Leukocytosis	Decrease (75%)
STZ-induced diabetes	Vascular leakage	Decrease (60%)
STZ-induced diabetes	Acellular capillaries	Decrease (45%)
STZ-induced diabetes	Vascular leakage	Decrease (60.0%)
Oxygen-induced retinopathy	Pre-retinal neovascularization	Decrease (34%)
Oxygen-induced retinopathy	Neovascularization area	Decrease (40%)
Oxygen-induced retinopathy	Vaso-obliteration area	Decrease (30%)

STZ: Streptozotocin.

Citation: Wang JJ, Zhu M, Le YZ. Functions of Müller cell-derived vascular endothelial growth factor in diabetic retinopathy. World J Diabetes 2015; 6(5): 726-733
URL: https://www.wjgnet.com/1948-9358/full/v6/i5/726.htm
DOI: https://dx.doi.org/10.4239/wjd.v6.i5.726